BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24119561)

  • 1. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
    Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
    Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma.
    Travaglino A; Raffone A; Arciuolo D; Santoro A; Inzani F; Di Maio A; Visiello U; Fulgione C; Guida M; Mollo A; Insabato L; Zannoni GF
    Pathol Res Pract; 2022 Sep; 237():154019. PubMed ID: 35907281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
    Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
    Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
    Wu HW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
    [No Abstract]   [Full Text] [Related]  

  • 5. Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.
    Pors J; Segura S; Cheng A; Ji JX; Tessier-Cloutier B; Cochrane D; Fix DJ; Park K; Gilks B; Hoang L
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):593-601. PubMed ID: 31361605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
    Reid-Nicholson M; Iyengar P; Hummer AJ; Linkov I; Asher M; Soslow RA
    Mod Pathol; 2006 Aug; 19(8):1091-100. PubMed ID: 16648864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of alpha-methylacyl-CoA racemase in vaginal gastric-type adenocarcinoma and uterine clear cell carcinoma.
    Hu J; Lu Y; Tang N; Li L; Guo P; Zhang Y
    Indian J Pathol Microbiol; 2020; 63(1):49-52. PubMed ID: 32031122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
    Fadare O; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Parkash V; Hecht JL
    Am J Surg Pathol; 2014 Feb; 38(2):189-96. PubMed ID: 24145649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial Serous Carcinoma With Clear-Cell Change: Frequency and Immunohistochemical Analysis.
    Hariri N; Qarmali M; Fadare O
    Int J Surg Pathol; 2018 Apr; 26(2):126-134. PubMed ID: 28954565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium.
    Nili F; Sadri M; Ameli F
    BMC Cancer; 2023 Apr; 23(1):332. PubMed ID: 37041497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
    Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
    Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
    Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP
    Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.
    Mhawech-Fauceglia P; Yan L; Liu S; Pejovic T
    Histopathology; 2013 Jun; 62(7):976-85. PubMed ID: 23570281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
    Yasuda M
    J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
    Zhou M; Jiang Z; Epstein JI
    Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation.
    Nakamura H; Kukita Y; Kunimasa K; Kittaka N; Kusama H; Nakayama T; Tamaki Y; Sugiura R; Yasuda H; Hashimoto M; Yamamoto T; Imamura F; Nakatsuka SI
    Hum Pathol; 2021 Oct; 116():39-48. PubMed ID: 34314764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue factor and heparanase in endometrial clear cell carcinoma: possible role for tissue factor in thromboembolic events.
    Fadare O; Renshaw IL; Liang SX
    Int J Gynecol Pathol; 2011 May; 30(3):252-61. PubMed ID: 21464728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.